Abstract
Current methods of analyzing the use of communication technologies in diabetes care improvement programs are limited by a poor understanding of the impact of technology on the delivery of care. We applied a standardized methodology using a functional framework to analyze 14 diabetes care improvement programs that used communications technology. Controlled trials and observational studies were selected after searching 5 electronic databases to identify care improvement programs for type 2 diabetes that used communications technology in the past 10 years with greater than 10 subjects. A 3-stage framework was used to analyze intervention elements: 1) functional components, 2) structural components, and 3) level of automation in program design. Using this methodology we found marked variability in operational design of programs and poor rationalization of choice of outcome metrics with program components. Although 11 of 14 studies showed significant declines in HbA1c, our analysis indicated that the causal pathways remain unclear. Recent systematic reviews have highlighted the difficulties in evaluating communication technology use in diabetes. The functional framework presented in this review provides a systems approach to the problem and represents a standardized methodology for analyzing communications technology use in diabetes care.
Keywords: HbA1C, communication technology, diabetes, automation, Patient care
Current Diabetes Reviews
Title: Connected Health: A New Framework for Evaluation of Communication Technology Use in Care Improvement Strategies for Type 2 Diabetes
Volume: 3 Issue: 4
Author(s): Anshul Mathur, Joseph C. Kvedar and Alice J. Watson
Affiliation:
Keywords: HbA1C, communication technology, diabetes, automation, Patient care
Abstract: Current methods of analyzing the use of communication technologies in diabetes care improvement programs are limited by a poor understanding of the impact of technology on the delivery of care. We applied a standardized methodology using a functional framework to analyze 14 diabetes care improvement programs that used communications technology. Controlled trials and observational studies were selected after searching 5 electronic databases to identify care improvement programs for type 2 diabetes that used communications technology in the past 10 years with greater than 10 subjects. A 3-stage framework was used to analyze intervention elements: 1) functional components, 2) structural components, and 3) level of automation in program design. Using this methodology we found marked variability in operational design of programs and poor rationalization of choice of outcome metrics with program components. Although 11 of 14 studies showed significant declines in HbA1c, our analysis indicated that the causal pathways remain unclear. Recent systematic reviews have highlighted the difficulties in evaluating communication technology use in diabetes. The functional framework presented in this review provides a systems approach to the problem and represents a standardized methodology for analyzing communications technology use in diabetes care.
Export Options
About this article
Cite this article as:
Mathur Anshul, Kvedar C. Joseph and Watson J. Alice, Connected Health: A New Framework for Evaluation of Communication Technology Use in Care Improvement Strategies for Type 2 Diabetes, Current Diabetes Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339907782330003
DOI https://dx.doi.org/10.2174/157339907782330003 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review on Rheumatoid Arthritis Interventions and Current Developments
Current Drug Targets Pre-CKD- Do we Need Another Hero?
Current Vascular Pharmacology Anti-angiogenic Drugs as an Adjunctive Therapy in the Surgical Treatment of Diabetic Retinopathy
Current Diabetes Reviews Adverse Drug Reactions in a Pulmonary Teaching Hospital: Incidence, Pattern, Seriousness, and Preventability
Current Drug Safety Clinical Significance of Umami Taste and Umami-Related Gene Expression Analysis for the Objective Assessment of Umami Taste Loss
Current Pharmaceutical Design An Atlas of Anionic Antimicrobial Peptides from Amphibians
Current Protein & Peptide Science Modulation of Individual Susceptibility to the No-Reflow Phenomenon after Acute Myocardial Infarction
Current Pharmaceutical Design Metformin Protects the Brain Against the Oxidative Imbalance Promoted by Type 2 Diabetes
Medicinal Chemistry AIDS-related Insulin Resistance and Lipodystrophy Syndrome
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Inflamm-ageing and senescence in gout: the tale of an old king’s disease.
Current Aging Science Drug-Induced Hypokalaemia
Current Drug Safety Dimeric NGF Mimetic Attenuates Hyperglycaemia and DNA Damage in Mice with Streptozotocin-Induced Early-Stage Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Factors Influencing Adherence Among Youth with Type-1-Diabetes Mellitus - The Hungarian Case
Current Diabetes Reviews Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations
Current Pharmaceutical Design Relationship between Proinflammatory Cytokines/Chemokines and Adipokines in Serum of Young Adults with Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia
Infectious Disorders - Drug Targets Paliperidone Use in the Elderly
Current Drug Safety PI3K Inhibitors for Cancer Therapy: What has been Achieved So Far?
Current Medicinal Chemistry Mazabraud's Syndrome: A Case Report and Up-To-Date Literature Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Functional and Molecular Changes of MSCs in Aging
Current Stem Cell Research & Therapy